Institutional investors purchased a net $26.0 million shares of MYL during the quarter ended September 2015. This may signal that the smart money is gaining interest in this company as the 82.36% of shares outstanding that institutional investors hold is actually below the Pharmaceuticals: Generic industry average.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
INVESCO ASSET MANAGEMENT LTD. Bought 6.7 Million shares of Mylan NV
WELLINGTON MANAGEMENT CO. LLP Bought 6.4 Million shares of Mylan NV
CARMIGNAC GESTION SA Bought 5.4 Million shares of Mylan NV